Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
MEPYRAMINE MALEATE BENZOCAINE
Seton Products Ltd
1/0.5 %w/w
Cutaneous Spray Solution
1996-07-09
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Wasp-eze Spray 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _For full list of excipients, see section 6.1._ 3 PHARMACEUTICAL FORM Cutaneous spray, solution. Clear, colourless solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of all insect bites and stings, nettle stings and jellyfish stings. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For cutaneous use. ADULTS, THE ELDERLY AND CHILDREN: Hold nozzle approximately five inches from the skin and spray once for 2-3 seconds. Stop spraying immediately if a white deposit or ‘frost’ appears. Repeat once after 15 minutes if necessary. If pain persists, seek medical advice. 4.3 CONTRAINDICATIONS Do not apply to broken skin. Do not use near the eyes. Do not use if you are sensitive to benzocaine. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Patients with any known allergy should seek medical advice. If pain persists, seek medical advice. For external use only. Keep out of the reach of children. Flammable. Do not use near fire or flame. Pressurised container. Protect from sunlight and do not expose to temperatures exceeding 50 ° C. Do not pierce or burn, even after use. Do not spray on a naked flame or any incandescent material. Do not use near or place container on polished or painted surfaces. Benzocaine 1.0% w/w Mepyramine maleate 0.5% w/w Excipients: Propylene glycol (E1520) 2.2% w/w IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 20/10/2010_ _CRN 2090814_ _page number: 1_ 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None known. 4.6 PREGNANCY AND LACTATION No known effects in pregnancy and lactation. However, as with all m Lue koko asiakirja